Pérez-Díaz Vicente, Pérez-Escudero Alfonso, Sanz-Ballesteros Sandra, Rodríguez-Portela Guadalupe, Valenciano-Martínez Susana, Palomo-Aparicio Sofía, Hernández-García Esther, Sánchez-García Luisa, Gordillo-Martín Raquel, Marcos-Sánchez Hortensia
Department of Nephrology, Hospital Clínico Universitario de Valladolid, Spain Department of Medicine, Dermatology and Toxicology, Facultad de Medicina, Universidad de Valladolid, Spain
Department of Physics, Massachusetts Institute of Technology, Cambridge, MA, USA.
Perit Dial Int. 2016;36(5):555-61. doi: 10.3747/pdi.2016.00007. Epub 2016 Jun 9.
♦
Peritoneal dialysis (PD) has limited power for liquid extraction (ultrafiltration), so fluid overload remains a major cause of treatment failure. ♦
We present steady concentration peritonal dialysis (SCPD), which increases ultrafiltration of PD exchanges by maintaining a constant peritoneal glucose concentration. This is achieved by infusing 50% glucose solution at a constant rate (typically 40 mL/h) during the 4-hour dwell of a 2-L 1.36% glucose exchange. We treated 21 fluid overload episodes on 6 PD patients with high or average-high peritoneal transport characteristics who refused hemodialysis as an alternative. Each treatment consisted of a single session with 1 to 4 SCPD exchanges (as needed). ♦
Ultrafiltration averaged 653 ± 363 mL/4 h - twice the ultrafiltration of the peritoneal equilibration test (PET) (300 ± 251 mL/4 h, p < 0.001) and 6-fold the daily ultrafiltration (100 ± 123 mL/4 h, p < 0.001). Serum and peritoneal glucose stability and dialysis efficacy were excellent (glycemia 126 ± 25 mg/dL, peritoneal glucose 1,830 ± 365 mg/dL, D/P creatinine 0.77 ± 0.08). The treatment reversed all episodes of fluid overload, avoiding transfer to hemodialysis. Ultrafiltration was proportional to fluid overload (p < 0.01) and inversely proportional to final peritoneal glucose concentration (p < 0.05). ♦
This preliminary clinical experience confirms the potential of SCPD to safely and effectively increase ultrafiltration of PD exchanges. It also shows peritoneal transport in a new dynamic context, enhancing the influence of factors unrelated to the osmotic gradient.
♦
腹膜透析(PD)的液体清除能力(超滤)有限,因此液体过载仍然是治疗失败的主要原因。♦
我们提出了稳定浓度腹膜透析(SCPD),通过维持恒定的腹膜葡萄糖浓度来增加PD交换的超滤量。这是通过在2升1.36%葡萄糖交换的4小时驻留期间以恒定速率(通常为40毫升/小时)输注50%葡萄糖溶液来实现的。我们对6例具有高或中高腹膜转运特征且拒绝接受血液透析替代治疗的PD患者的21次液体过载发作进行了治疗。每次治疗包括根据需要进行1至4次SCPD交换的单次治疗。♦
超滤平均为653±363毫升/4小时,是腹膜平衡试验(PET)超滤量(300±251毫升/4小时,p<0.001)的两倍,是每日超滤量(100±123毫升/4小时,p<0.001)的6倍。血清和腹膜葡萄糖稳定性以及透析效果良好(血糖126±25毫克/分升,腹膜葡萄糖1830±365毫克/分升,D/P肌酐0.77±0.08)。该治疗逆转了所有液体过载发作,避免了转为血液透析。超滤与液体过载成正比(p<0.01),与最终腹膜葡萄糖浓度成反比(p<0.05)。♦
这一初步临床经验证实了SCPD安全有效地增加PD交换超滤量的潜力。它还在新的动态背景下展示了腹膜转运,增强了与渗透梯度无关的因素的影响。